The first long-term data from a high-blood-pressure study, the Systolic Hypertension in the Elderly Program (SHEP), show that each month of chlorthalidone-based therapy was associated with approximately one day of extension in life, free from cardiovascular death.Imagine how much longer people would live if they did not develop hypertension and were not on meds.
"The main findings are that after 22 years of follow-up, when about 60% of the participants in SHEP were dead, we saw a prolonged life expectancy in those who took the active treatment for 4.5 years, and that is the first time this has been reported in studies of hypertension, because you have to wait a long time to find out differences in life expectancy," lead author Dr John B Kostis (UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ) told heartwire . "In hypertension trials, by the time everybody dies, the investigators have died," he added.
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Sunday, December 25, 2011
First Data to Show Antihypertensive Therapy Prolongs Life
Fat, unfit people are more likely to be hypertensive than intended-size, fit people.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.